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Abbreviations 
 
2D   two-dimensional 
3D   three-dimensional 
3DS   three-dimensional strain 
3DSTE  three-dimensional speckle-tracking echocardiography 
AAEF   active atrial emptying fraction 
AASV   active atrial stroke volume 
AP2CH  apical 2-chamber view 
AP4CH  apical 4-chamber view 
AS   area strain 
CMR   cardiovascular magnetic resonance 
CT   computed tomography 
CS   circumferential strain 
DM   diabetes mellitus 
EDV   end-diastolic volume 
EF   ejection fraction  
EFO   ejection force 
ESV   end-systolic volume 
HCM   hypertrophic cardiomyopathy 
L   left atrial long axis 
LA   left atrial 
LAA   left atrial appendage 
LA-EFO  left atrial ejection force 
LS   longitudinal strain 
LV   left ventricular 
LVOT   left ventricular outflow tract 
MA   mitral annulus 
MAA-D  end-diastolic mitral annular area 
MAAI-D  end-diastolic mitral annular area index 
MAAI-S  end-systolic mitral annular area index 
MAA-S  end-systolic mitral annular area 
MAD-D  end-diastolic MA diameter 
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MADI-D  end-diastolic mitral annular diameter index 
MADI-S  end-systolic mitral annular diameter index 
MAD-S  end-systolic mitral annular diameter 
MAFAC  mitral annular fractional area change 
MAFS   mitral annular fractional shortening 
’MAGYAR’ ’Motion Analysis of the heart and Great vessels bY three-dimensionAl 
speckle-tRacking echocardiography’ 
MAP-D  end-diastolic mitral annular perimeter 
MAPI-D  end-diastolic MA perimeter index 
MAP-S  end-systolic MA perimeter  
MAPI-S  end-systolic MA perimeter index 
MR   mitral regurgitation 
MRI   magnetic resonance imaging 
NCCM  noncompaction cardiomyopathy 
PAEF   passive atrial emptying fraction 
PASV   passive atrial stroke volume 
RS   radial strain 
RT3DE  real-time three-dimensional echocardiography 
STE   speckle-tracking echocardiography 
SV   stroke volume 
TAEF   total atrial emptying fraction 
TASV   total atrial stroke volume 
TDI   tissue doppler imaging 
Vmax   maximum left atrial volume 
Vmin   minimum left atrial volume 
VpreA   left atrial volume before atrial contraction 
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1. Introduction  
 
Noninvasive accurate assessment of left atrial (LA) size and function is an essential 
requirement in daily clinical practice (1). LA is a dynamically moving cardiac chamber, 
which acts as a reservoir during the cardiac cycle, receiving pulmonary venous return in left 
ventricular (LV) systole, works as a conduit, passively transferring blood to the LV during 
early diastole and have a booster pump function in late diastole (2). To perform these 
complicated cardiac motions, condition and function of both the pulmonary veins and the 
mitral valve have an essential role.  
 
Two-dimensional (2D) echocardiography is one of the most widely used standardized 
imaging tool for the evaluation of LA dimensions in the real clinical practice (3). Today, 
different kinds of 3D echocardiographic methods are available based on different algorithms: 
besides the volumetric real-time 3D echocardiography (RT3DE) (4), 3D speckle-tracking 
echocardiography (STE) has been introduced in the latter years (5). Early results have already 
raised confirming that RT3DE seems to be a proper solution to assess the LA and mitral 
annular (MA) periodic functions respecting cardiac cycle (6-10). RT3DE with direct 
volumetric assessment has been found to be a highly accurate and reproducible non-invasive 
tool for the evaluation of LA dimensions and functional properties (6,7). 3DSTE uses 
different, as called „block-matching” algorithm by strain analyis during evaluations. It has 
been validated mostly for LV volumetric measurements (5). This methodology tries to merge 
advantages of 3D echocardiography and STE: while heart could be examined according to its 
nature in 3D, segmental motions could be quantified by strain analysis with STE, as well (5). 
In a recent study, RT3DE and 3DSTE methods for quantification of LV and LA volumes and 
functional properties were found to be comparable, reproducible and interchangeable (11). 
 
However, there is limited information on the validity of 3DSTE-derived LA 
dimensions and functional data. Moreover, the relationship between LA and MA data as 
assessed simultaneously by 3DSTE has also not been confirmed even in healthy subjects. 
There was no information on the usefulness of 3DSTE in the evaluation of LA appendage, as 
well. 
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Noncompaction cardiomyopathy (NCCM) is a rare congenital disease, which is likely 
to develop in the embryonic period and is characterized by prominent myocardial 
trabeculations and deep intertrabecular recesses (12). NCCM is caused by the intrauterine 
arrest of the myocardial compaction process in the beginning of the fetal development. 
NCCM is frequently associated with arrhythmias, thrombembolic events and heart failure. 
Due to guidelines for treatment of arrhythmias, the accurate evaluation of LA size and 
function would be essential in this disease. 
 
Hypertrophic cardiomyopathy (HCM) is a complex, relatively common genetic 
cardiac disease, that is heterogeneous with respect to gene mutations, clinical symptoms, 
prognosis, and treatment strategies (13). HCM represents a generalized myopathic process 
affecting both ventricular and atrial myocardium (14). Most of the patients are in steady 
condition, although HCM is known as one of the most common cause of sudden death in 
juvenile patients (13). HCM is characterised by excessive asymmetric LV hypertrophy 
involving primarily the interventricular septum (13). It is known, that diastolic LV 
dysfunction is more common in HCM than systolic dysfunction. Due to reduced ventricular 
compliance and impaired relaxation, elevated LA and pulmonary vascular pressures are 
known complications in HCM (15). Due to sensitivity of thin-walled LA to volume and 
pressure changes, increased LV load pressure could lead to LA dilation which is known to be 
associated with increased morbidity and mortality in HCM (16). Enlarged LA volume was 
found to be associated with impaired functional NYHA class and shows inverse correlation 
with treadmill exercise capacity in HCM (17). P-wave duration combined with LA antero-
posterior diameter and myocardial deformation indices resulted in a higher power for 
discriminating HCM patients with paroxysmal atrial fibrillation. All these studies should draw 
our attention to the importance of accurate evaluation of LA volumes and function respecting 
cardiac cycle in HCM (18,19). 
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2. Aims 
 
To compare 2D echocardiography with 3DSTE for calculation of LA volumes and assessment 
of LA functional properties in healthy subjects. 
 
To evaluate the relationship between 3DSTE-derived LA and MA morphologic and functional 
parameters in healthy volunteers. 
 
To demonstrate alternative ways in assessing LA (dys)function in NCCM by 3DSTE. 
 
To measure and compare 3DSTE-derived LA volumetric and strain parameters in HCM and 
healthy matched controls. 
 
To demonstrate the usefulness of 3DSTE in the visualisation and evaluation of the LA 
appendage. 
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3. Methods 
 
Patient population (general considerations). All healthy subjects and patients have been 
included in the MAGYAR-Healthy Study and MAGYAR-Path Study (Motion Analysis of 
the heart and Great vessels bY three-dimensionAl speckle-tRacking echocardiography in 
Healthy subjects and in Pathological cases). These have been organized at the Cardiology 
Center of the University of Szeged, Hungary to evaluate usefulness, diagnostic and prognostic 
value of 3DSTE-derived volumetric, strain, rotational etc. parameters in healthy volunteers as 
well as in pathological cases (’magyar’ means ’Hungarian’ in Hungarian language). In all 
patients complete 2D Doppler echocardiography study was performed extended with 3DSTE 
measurements. In healthy volunteers there was no any disease or other condition, which could 
influence results. Informed consent was obtained from each patient and the study protocol 
conformed to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected in a 
priori approval by the institution’s human research committee (20). 
 
Two-dimensional echocardiography. Complete 2-dimensional (2D) Doppler 
echocardiographic examinations were performed in all cases. Standard 2D echocardiographic 
studies were carried out with a commercially available Toshiba Artida
TM 
echocardiography 
equipment (Toshiba Medical Systems, Tokyo, Japan) with a PST-30SBP (1-5 MHz) phased-
array transducer. LV dimensions, volumes and ejection fraction and LA dimensions were 
measured in parasternal long-axis view by Teichholz method. Colour Doppler 
echocardiography was used to visually quantify degree of mitral regurgitation (MR).  
 
In some studies, for evaluation of LA size and function, the following parameters were 
measured on 2D images (Figure 1):  
1) LA area at apical 4-chamber view (AP4CH) (A1) by manual tracing of LA endocardial 
border. The superior border of atrial outline was a straight line connecting both sides 
of the mitral leaflet base attachment points. Both LA appendage and pulmonary veins 
were excluded when visualized, and  
2) LA area at apical 2-chamber (AP2CH) (A2) with same tracing, and LA long axis (L) 
defined as the distance of the perpendicular line measured from the middle of the 
plane of mitral annulus to the superior aspect of LA in both apical 4CH and 2CH 
views and the shortest of both lines was used. 
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Figure 1. Calculation of left atrial (LA) volume using 2-dimensional echocardiography 
by manual tracing of LA endocardial border at apical 4-chamber (AP4CH) and 2-
chamber views (AP2CH). L is the long axis, then apply the formula. 
 
Abbreviations: LV: left ventricle, RA: right atrium, RV: right ventricle 
 
 
3DSTE volumetric measurements. All patients underwent 3D echocardiographic 
acquisitions immediately following 2D echocardiographic study using a commercially 
available 1-4 MHz matrix-array PST-25SX transducer (Toshiba Medical Systems, Tokyo, 
Japan) with 3DSTE capability (11,21-23). Within a single breath-hold and during a constant 
RR interval, 6 wedge-shaped subvolumes were acquired from an apical window to create full-
volume 3D datasets including LA. The sector width was decreased as much as possible to 
improve temporal and spatial resolution of the image in order to obtain a full-volume dataset 
of LA with optimal border delineation. Chamber quantification by 3DSTE was performed off-
line using 3D Wall Motion Tracking software version 2.7 (Toshiba Medical Systems, Tokyo, 
Japan). 3D echocardiographic datasets were displayed in AP4CH and AP2CH views and 3 
short-axis views in basal, midatrial, and superior LA regions, respectively (Figure 2). In the 
AP4CH and AP2CH views, the endocardial border was traced by setting multiple reference 
points by the user starting at base of the LA at mitral valve level on the septal side, where 
anterior mitral leaflet origins going toward the apex on counterclockwise direction to the 
origin of the mitral posterior leaflet excluding the LA appendage and the pulmonary veins 
from the LA cavity. Measurements were performed firstly on AP4CH view, and later on AP 
2CH view. After detection of the myocardial borders at the end-diastolic reference frame, the 
user could correct the LA shape, if necessary. The 3D wall motion tracking was then 
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automatically performed through the entire cardiac cycle. 3D cast and volumetric data of LA 
at different moments of cardiac cycle were generated by the software (Figure 2). 
 
 
Figure 2. Three-dimensional echocardiographic dataset is displayed in apical 4-chamber 
(A) and 2-chamber views (B) and 3 short-axis views in the basal (C3), midatrial (C5), 
and apical (C7) regions, respectively. Three-dimensional LA cast is also presented. 
 
Abbreviations: LV: left ventricle, RA: right atrium, RV: right ventricle 
 
 
The epicardial border was adjusted manually or by setting a default thickness for the 
myocardium. After detection of the LA borders at the end-diastolic reference frame 3D wall 
motion tracking, which is based on 3D block-matching algorithm, was automatically 
performed by the software. The user could correct the shape of the LA if needed throughout 
the entire cardiac cycle. 
 The following volumetric calculations have been performed (Figure 3) (6):  
[1] maximum volume (Vmax) at end-systole, the time at which atrial volume was largest just 
before mitral valve opening,  
[2] minimum volume (Vmin): at end-diastole, the time at which atrial volume is at its nadir 
before mitral valve closure,  
[3] volume before atrial contraction (VpreA): the last frame before mitral valve reopening or 
at the time of P wave on ECG. 
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Figure 3. Volume changes in the LA during heart cycle 
 
From the three volumes several parameters characterizing each phasis of LA function were 
assessed (Table 1).  
 
Table 1. The way to calculate left atrial stroke volumes and emptying fractions in each 
phasis of left atrial motion.  
 
Functions Stroke volumes 
(ml) 
Emptying fractions 
(%) 
Reservoir Total atrial SV 
(TASV) = 
Vmax-Vmin 
Total atrial EF 
(TAEF) = 
Total SV/Vmax 
Conduit function Passive atrial SV 
(PASV) = 
Vmax-VpreA 
Passive atrial EF 
(PAEF) = 
Passive SV/Vmax 
Active contraction Active atrial SV  
(AASV) = 
VpreA-Vmin 
Active atrial EF  
(AAEF) = 
Active SV/VpreA 
 
Abbreviations: EF: emptying fraction, SV: stroke volume, Vmax: maximum left atrial 
volume, Vmin: minimum left atrial volume, VpreA: left atrial volume before left atrial 
contraction 
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3DSTE strain measurements. The following strain parameters were routinely measured by 
the software in a semi-automatic fashion from the 3D echocardiographic dataset in some 
studies: longitudinal strain (LS) in the direction tangential to the endocardial contour, 
circumferential strain (CS) in circumferential direction and radial strain (RS) in perpendicular 
direction to the endocardial contour. Besides these ’unidimensional’ parameters, novel strain 
parameters using 3D wall motion tracking were also recorded, such as 3D strain (3DS) 
defined as strain in the direction of wall thickening and area strain (AS) as a ratio of 
endocardial area change during the cardiac cycle (21,22). Examples of time-strain curves 
generated by the software are given in Figure 4.  
 
 
Figure 4. Examples of time-strain curves of 16 left atrial segments in a healthy control 
subject (A) and in a patient with hypertrophic cardiomyopathy (B). 
 
 
3DSTE for the measurement of MA. MA diameter could be easily measured from the 
digitally collected 3D echocardiographic database by the special software. Longitudinal 
planes were optimized to the LV longitudinal axis in AP4CH and AP2CH views, then we set 
optional cross-sectional plain (the lowest, C7 is the practical) to the endpoints of MA in both 
views. In this case MA front-wise (“en-face”) could be visualized on the cross-sectional plain 
(e.g. C7), where the MA area could be measured by planimetry and the largest MA (cross-) 
diameter could be selected. The measurements were performed in systole and in diastole, as 
well (Figure 5). The following measurements have been performed:  
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- end-diastolic and end-systolic MA diameters (MAD)  
- end-diastolic and end-systolic MA diameter indices (MADI) = MAD/BSA  
- end-diastolic and end-systolic MA areas (MAA) 
- end-diastolic and end-systolic MA area indices (MAAI) = MAA/BSA 
- end-diastolic and end-systolic MA perimeter (MAP)  
- end-diastolic and end-systolic MA perimeter index (MAPI) = MAP/BSA  
 
From the above detailed morphologic data the following MA functional parameters have been 
calculated (8-10): 
 
- MA fractional shortening (MAFS) = (end-diastolic MAD – end-systolic MAD) / end-
diastolic MAD x 100 (%) 
- MA fractional area change (MAFAC) = (end-diastolic MAA – end-systolic MAA) / 
end-diastolic MAA x 100 (%) 
 
 
Figure 5 Evaluation of the mitral annulus (MA) by three-dimensional speckle-tracking 
echocardiography. Longitudinal planes were optimalized to the left atrial longitudinal 
axis in apical four-chamber (A) and two chamber (B) views created from the three-
dimensional “echo-cloud” by the software, then an optional cross-sectional image (e.g. 
C7) has been inserted to the endpoints of the mitral annulus in both views. In the cross-
sectional (C7) image the MA is visualized front-wise (“en-face”), where the MA area and 
perimeter can be measured with planimetry, and the largest MA (cross-) diameter can 
be selected. 
 
Abbreviations: Area: mitral annulus area, Circ: mitral annulus perimeter, Dist: mitral annulus 
diameter 
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Stastical analysis. Data are reported as mean  standard deviation. A value of p <0.05 was 
considered to be statistically significant. MedCalc software was used for statistical 
calculations (MedCalc, Mariakerke, Belgium). Paired sample t-test and Chi-square test were 
used for comparisons. Pearson's coefficient was used for interobserver and intraobserver and 
other correlations. Intra- and interobserver agreements were studied according to Bland and 
Altman method (24).  
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4. Results 
4.1. Comparison of three-dimensional speckle-tracking echocardiography and two-
dimensional echocardiography for evaluation of left atrial size and function in healthy 
volunteers 
 
Study population. The present work comprised randomly selected 35 healthy subjects (mean 
age: 40.9 ± 10.9 years, 20 men) in sinus rhythm, they all had undergone standard transthoracic 
Doppler 2D echocardiographic study extended with 3DSTE.  
 
Volumetric 3DSTE and 2D echocardiographic data. Volumetric data and functional 
parameters of LA are presented in Table 2.  
 
Table 2. Left atrial dimensions and functional parameters using two-dimensional 
echocardiography and three-dimensional speckle-tracking echocardiography in healthy 
controls 
 
 2D echocardiography 3DSTE p 
Calculated LA volumes    
  Vmax (ml) 35.5 ± 0.7 36.6 ± 6.5 NS  
  Vmin (ml) 14.9 ± 0.4 16.5 ± 5.0 NS  
  VpreA (ml) 23.8 ± 4.8 24.0 ± 6.1 NS  
LA stroke volumes    
  TASV (ml) 20.6 ± 5.9 20.1 ± 5.0 NS 
  PASV (ml) 12.1 ± 4.3 12.3 ± 5.0 NS 
  AASV (ml) 8.8 ± 3.8 7.5 ± 2.9  NS  
LA emptying fractions    
  TAEF (%) 57.6 ± 10.0 55.2 ± 10.7  NS  
  PAEF (%) 32.0 ± 11.9 34.6 ± 11.3 NS  
  AAEF (%) 37.0 ± 13.8 31.5 ± 9.5 < 0.05 
 
Abbreviations: AAEF: Active Atrial Emptying Fraction, AASV: Active Atrial Stroke 
Volume, PAEF: Passive Atrial Emptying Fraction, PASV: Passive Atrial Stroke Volume, 
TAEF: Total Atrial Emptying Fraction, TASV: Total Atrial Stroke Volume, Vmax: maximum 
volume at end-systole, Vmin: minimum volume at end-diastole, VpreA: volume before atrial 
contraction, 2D: 2-dimensional, 3DSTE: three-dimensional speckle-tracking 
echocardiography 
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Correlations between 3DSTE-derived and 2D echocardiographic data. A good correlation 
was found between both techniques for Vmax (r =0.93, p <0.0001), Vmin (r =0.62, p 
<0.0001) and VpreA (r =0.74, p <0.0001). Similar correlations were found between TASV (r 
=0.85, p <0.0001), TAEF (r =0.81, p <0.0001), PASV (r =0.67, p <0.0001), PAEF (r =0.74, p 
<0.0001), AASV (r =0.71, p <0.0001) and AAEF (r =0.69, p <0.0001).  
 
Reproducibility of measurements. The mean ± standard deviation difference in values 
obtained by 2 mesurements of the same observer for the measurements of 3DSTE-derived 
Vmax, Vmin and VpreA was –0.8 ± 9.3 ml, -0.5 ± 6.6 ml, -1.5 ± 8.0 ml, respectively. 
Correlation coefficients between measurements of 2 observers were 0.76, 0.79 and 0.82 (p 
<0.0001), respectively (Figures 3-5) (intraobserver agreement). The mean ± standard 
deviation difference in values obtained by two observers for 3DSTE-derived Vmax, Vmin and 
VpreA was 0.9 ± 9.3 ml, -0.3 ± 7.4 ml, -0.5 ± 7.3 ml, respectively. Correlation coefficient 
between these independent measurements of the same observer were 0.75, 0.77 and 0.82 (p 
<0.0001), respectively (Figures 6-8) (interobserver agreement). 
 
 
Figure 6. Intraobserver (upper graphs) and interobserver (lower graphs) agreements 
and correlations for measuring Vmax by three-dimensional speckle-tracking 
echocardiography are presented. 
 
Abbreviations: Vmax: maximum left atrial volume, 3DSTE: three-dimensional speckle-
tracking echocardiography 
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Figure 7. Intraobserver (upper graphs) and interobserver (lower graphs) agreements 
and correlations for measuring Vmin by three-dimensional speckle-tracking 
echocardiography are presented. 
Abbreviations: Vmax: minimum left atrial volume, 3DSTE: three-dimensional speckle-
tracking echocardiography 
 
 
 
Figure 8. Intraobserver (upper graphs) and interobserver (lower graphs) agreements 
and correlations for measuring VpreA by three-dimensional speckle-tracking 
echocardiography are presented. 
Abbreviations: VpreA: volume before atrial contraction, 3DSTE: three-dimensional speckle-
tracking echocardiography 
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4.2. Relationship between mitral annular and left atrial function as assessed by three-
dimensional speckle-tracking echocardiography in healthy volunteers 
 
 
Study population. The present study comprised 35 randomly selected healthy individuals 
(mean age: 35.9 ± 11.1 years, 20 men).  
 
 
Clinical and routine 2D echocardiographic data are showen in the Table 3. 
 
 
Table 3. Clinical and echocardiographic data 
 
  values 
  n  35 
  Age (years)  35.9 ± 11.1 
  Male gender (%)  20 (57)  
  BSA (m
2
)   1.93 ± 0.19 
Two-dimensional echocardiography   
  LA diameter (in parasternal long axis view) (mm) 
  LV end-diastolic diameter (mm) 
 33.6 ± 3.6 
46.9 ± 6.4 
  LV end-diastolic volume (ml)  98.9 ± 24.3 
  LV end-systolic diameter (mm)  30.3 ± 4.5 
  LV end-systolic volume (ml)  36.0 ± 13.2 
  Interventricular septum (mm)  9.7 ± 1.9 
  LV posterior wall (mm)  10.1 ± 2.1 
  LV ejection fraction (%)  63.7 ± 8.1 
 
Abbreviations: LV: left ventricle, LA: left atrium, BSA: body surface area 
 
 
3DSTE-derived LA and MA parameters. Volumetric LA parameters are demonstrated in 
Table 4. 
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Table 4. Left atrial dimensions and calculated volumetric functional parameters using 
three-dimensional speckle-tracking echocardiography 
 
  values 
Calculated LA volumes   
  Vmax (ml)  36.6 ± 6.5 
  Vmin (ml)  16.5 ± 5.0 
  VpreA (ml)  24.0 ± 6.1 
Stroke volumes    
  TASV (ml)  20.1 ± 5.0 
  PASV (ml)  12.7 ± 4.7 
  AASV (ml)  7.5 ± 2.9 
Emptying fractions   
  TAEF (%)  55.2 ± 10.7 
  PAEF (%)  34.6 ± 11.3 
  AAEF (%)  31.5 ± 9.5 
 
Abbreviations: AAEF: active atrial emptying fraction, AASV: active atrial stroke volume, 
PAEF: passive atrial emptying fraction, PASV: passive atrial stroke volume, TAEF: total 
atrila emptying fraction, TASV: total atrial stroke volume, Vmax: maximal left atrial volume, 
Vmin: minimal left atrial volume, VpreA: volume before atrial contraction 
 
 
The parameters measured with 3DSTE, which describes morphology and function of the MA 
are shown in Table 5. 
 
Relationships between LA volumes and MA data as assessed by 3DSTE. The Vmax 
correlated with diastolic MAA (R =0.43, p =0.01), MAP (R =0.53, p =0.01), as well as with 
systolic MAA (R =0.49, p =0.003), MAAI (R =0.37, p =0.03) and MAP (R =0.52, p =0.001). 
The Vmin showed correlations with systolic MAA (R =0.43, p =0.01) and MAP (R =0.35, p 
=0.04). The VpreA showed similar correlations with systolic MAA (R =0.47, p =0.004), 
MAAI (R =0.33, p =0.05) and MAP (R =0.41, p =0.01). MAFAC and MAFS did not 
correlated with any of LA volumes. 
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Table 5. Morphologic and functional parameters of the mitral annulus as assessed by 
three-dimensional speckle-tracking echocardiography 
 
       values 
Morphologic parameters – diastole  
  end-diastolic MA diameter (MAD-D) (mm) 2.72 ± 0.36 
  end-diastolic MA diameter index  (MADI-D) (mm/m
2
) 1.42 ± 0.23 
  end-diastolic MA area (MAA-D) 8.36 ± 1.96 
  end-diastolic MA area index (MAAI-D) (mm/m
2
) 4.36 ± 0.98 
  end-diastolic MA perimeter (MAP-D) 10.72 ± 1.25 
  end-diastolic MA perimeter index (MAPI-D) (mm/m
2
) 5.61 ± 0.73 
Morphologic parameters –systole  
  end-systolic MA diameter (MAD-S) (mm) 2.07 ± 0.31 
  end-systolic MA diameter index (MADI-S) (mm/m
2
) 1.08 ± 0.17 
  end-systolic MA area (MAA-S) (mm) 4.71 ± 1.01 
  end-systolic MA area index (MAAI-S) (mm/m
2
)  2.45 ± 0.49 
  end-systolic MA perimeter (MAP-S) (mm) 8.07 ± 0.88 
  end-systolic MA perimeter index (MAPI-S) (mm/m
2
) 4.22 ± 0.51 
Functional parameters  
  MAFAC (%) 42.7 ± 11.3 
  MAFS (%) 24.5 ± 13.4 
 
Abbreviations: MA: mitral annulus, MAFAC: mitral annulus fractional area change, MAFS: 
mitral annulus fractional shortening 
 
 
Relationships between LA volumetric functional parameters and MA data as assessed 
by 3DSTE. Only TASV and PASV showed correlations with MA parameters. TASV 
correlated with diastolic MAA (R =0.39, p =0.03), MAAI (R =0.38, p =0.02), MAP (R =0.42, 
p =0.01), and MAPI (R =0.40, p =0.02), and systolic MAP (R=0.32, p=0.05), MAPI (R =0.32, 
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p =0.05), and MAFS (R =0.43, p=0.02). The PASV showed correlations with diastolic MAA 
(R =0.31, p =0.07), MAAI (R =0.34, p =0.05), MAP (R =0.40, p =0.02), MAPI (R =0.38, p 
=0.03) and MAFS (R =0.33, p =0.07). AASV and emptying fractions did not show any 
correlations with the above mentioned parameters. 
 
 
4.3. Alternative ways to assess left atrial function in noncompaction cardiomyopathy by 
three-dimensional speckle-tracking echocardiography 
 
Case study. A 60 year-old patient with typical features of NCCM is demonstrated (Figure 9). 
 
 
 
Figure 9. Two-dimensional echocardiographic images with four-chamber (A) and two-
chamber views (B). Noncompaction cardiomyopathy is characterized by prominent 
myocardial trabeculations and deep intertrabecular recesses (see white arrows). 
 
Abbreviations: LA: left atrium, LV: left ventricle, MV: mitral valve, RA: right atrium, 
RV: right ventricle. 
 
 
3DSTE has been performed to analyse LA morphology and function as described previously 
in the Methods section (Figure 10).  
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Figure 10. Three-dimensional echocardiographic dataset is displayed in apical 4-
chamber (A) and 2-chamber views (B) and 3 short-axis views in the basal (C3), midatrial 
(C5), and apical (C7) regions, respectively. Three-dimensional cast (D) and calculated 
characteristics of left atrium are also presented (E). 
 
Abbreviations: LA: left atrium, LV: left ventricle, RA: right atrium, RV: right ventricle. 
 
 
LA functional parameters based on volumetric data could have been calculated as described 
previously (3). From 3D echocardiographic datasets, the MA could also be obtained by 
optimizing cross-sectional planes on the apical AP4CH and AP2CH views and therefore 
demonstrating the optimal image at the level of MA as already shown (Figure 11).  
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Figure 11. From 3D echocardiographic dataset, the mitral annulus (MA) could be 
obtained by optimizing cross-sectional planes on the apical 4-chamber (A) and 2-
chamber (B) views and therefore demonstrating the optimal MA image (C). Using 
Doppler-derived mitral inflow peak A wave velocity, the left atrial ejection force (LA-
EFO), a characteristic of left atrial systolic function, were calculated. 
 
Abbreviations: LA: left atrium, LV: left ventricle, LVOT: left ventricular outflow tract, MV: 
mitral valve, RA: right atrium, RV: right ventricle, E and A: Doppler-derived mitral inflow 
velocities. 
 
 
According to the Newton's second law of motion, the force generated by the LA in pushing 
blood forward into the LV during LA systole, is defined as the product of the mass and 
acceleration of blood ejected from the LA during the accelerative phase of LA systole (25). 
Mass may be further defined as the product of the blood density (1.06 g/cm
3
) and the volume 
of blood passing through the MA. This volume may be evaluated as the product of the MA 
area and the area under the transmitral Doppler A wave from onset of the A wave to peak A 
wave velocity (V) (25). The area under the accelerative portion of the A wave may be 
approximated as one-half the product of the peak A wave velocity and the time to peak A 
wave velocity. Because A wave acceleration is relatively constant, it can be approximated as 
the peak A velocity divided by the time to peak A velocity (25). Using MAD and MAA data, 
LA-EFO3D-MAD and LA-EFO3D-MAA were calculated using the following equation: LAEFO= 
0.5×1.06×(MAD3D or MAA3D)×V
2
 (25, 26), where 0.5 is a coefficient factor. LA-EFO3D-MAD 
and LAEFO3D-MAA were 3.8 kdyne and 13.5 kdyne in this case. 
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4.4. Three-dimensional speckle-tracking echocardiography allows detailed evaluation of 
left atrial function in hypertrophic cardiomyopathy 
 
Patient population. A total of 23 patients with typical features of HCM were included in the 
present study. The diagnosis of HCM was confirmed in all patients according to the 
guidelines (27). In all cases, hypertrophy was asymmetrical and had septal localization. HCM 
was known for several years in these patients, and 75% of the cases were genetically analysed 
with genotype/mutation analysis. Their results were compared to 23 age- and gender-matched 
healthy controls. Diabetes mellitus (DM) was defined in accordance with the American 
Diabetes Association and World Health Organization criteria. Hypertension was defined as 
either a systolic or a diastolic elevation of the blood pressure (>140/90 mmHg) or ongoing 
antihypertensive therapy. Hypercholesterolemia was defined as a total cholesterol level >5.0 
mmol/L or current treatment with lipid-lowering medications.  
 
Clinical characteristics are presented in Table 2. Eleven out of 23 HCM patients had 
significant (>30 mmHg) resting peak LV outflow tract gradient (mean: 69.5 ± 30.1 mmHg), 
while 15 HCM patients had systolic anterior motion of the anterior leaflet of the mitral valve. 
Other 3 HCM patients had implantable cardiac defibrillator due to prophylaxis of malignant 
arrhythmia and 1 HCM patient had biological prosthetic valve in aortic position. One HCM 
patient had former percutaneous transluminal septal myocardial ablation. 
 
Two-dimensional echocardiographic data. Standard 2D echocardiographic data are 
summarized in Table 2. Significant (≥grade 2) MR could be detected in 7 HCM patients 
(30%). LV end-systolic diameter was significantly decreased, while interventricular septum 
was significantly increased in HCM patients (Table 6).  
 
3DSTE data. Significantly increased LA volumes respecting heart cycle could be detected in 
HCM patients. TASV and AASV were significantly increased, while TAEF and PAEF were 
significantly decreased in patients with HCM (Table 7). Global and mean segmental peak 
strain parameters proved to be reduced in HCM patients as compared to controls (Table 8). 
There were no differences between HCM patients with vs. without hypertension and/or DM in 
this patient population in both LA volumetric and strain functional properties. Calculated LA 
volumes were significantly larger in HCM patients with MR ≥2 vs. cases with MR <2, only 
TAEF showed significant difference from calculated parameters. There were no differences 
between HCM patients with MR ≥2 vs. MR <2 in strain parameters.  
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Table 6. Clinical and two-dimensional echocardiographic characteristics of 
hypertrophic cardiomyopathy patients and controls 
 
 HCM patients 
(n = 23) 
Controls 
(n = 23) 
Risk factors   
  Age (years) 48.5 ± 15.1 41.0 ± 11.8 
  Male gender (%) 14 (61) 13 (57) 
  Body mass index (kg/m
2
) 27.4 ± 5.0 25.3 ± 3.5 
  Diabetes mellitus (%) 10 (44)* 0 (0) 
  Hypertension (%) 11 (48)* 0 (0) 
  Hypercholesterolaemia (%) 2 (9)* 0 (0) 
Medications   
  β-blockers (%) 20 (87)* 0 (0) 
  ACE-inhibitors (%) 8 (35)* 0 (0) 
  Diuretics (%) 8 (35)* 0 (0) 
Two-dimensional echocardiography   
  LA diameter (mm) 46.2 ± 5.2† 33.8 ± 3.9 
  LV end-diastolic diameter (mm) 45.1 ± 3.9 46.3 ± 5.1 
  LV end-diastolic volume (ml) 95.5 ± 23.4 100.2 ± 26.8 
  LV end-systolic diameter (mm) 27.3 ± 4.8* 31.2 ± 4.9 
  LV end-systolic volume (ml) 29.9 ± 13.1 37.9 ± 15.2 
  Interventricular septum (mm) 22.8 ± 5.6† 9.2 ± 2.1 
  LV posterior wall (mm) 12.1 ± 4.2 10.6 ± 2.2 
  LV ejection fraction (%) 68.4 ± 7.6 68.6 ± 7.7 
  E/A 1.04 ± 0.53 1.21 ± 0.30 
 
Abbreviations: ACE: angiotensin-converting enzyme, LA: left atrial, LV : left ventricular, 
HCM: hypertrophic cardiomyopathy 
 
*p =0.02 vs. Controls, †p =0.0001 vs. Controls 
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Table 7. Comparison of 3DSTE-derived volumetric left atrial parameters of patients with hypertrophic cardiomyopathy and controls 
 
 
Controls 
(n=23) 
HCM patients 
(n=23) 
HCM patients 
with 
hypertension 
and/or DM 
(n=10) 
HCM patients 
without 
hypertension 
and/or DM 
(n=13) 
HCM patients 
with MR ≥2 
(n=9) 
HCM 
patients with 
MR <2 
(n=14) 
Calculated Volumes        
  Vmax (ml) 36.0 ± 6.1 66.4 ± 20.4* 65.2 ±10.7* 67.2 ± 26.0* 76.2 ± 26.0*‡ 59.0 ± 13.3* 
  Vmin (ml) 16.0 ± 4.6 39.2 ± 19.1* 38.9 ± 14.1* 39.4 ± 22.7* 46.6 ± 23.8*‡ 32.7 ± 13.3* 
  VpreA (ml) 24.0 ± 6.2 53.6 ± 19.9* 54.0 ± 12.6* 53.3 ± 24.5* 64.1 ± 22.4*‡ 45.3 ± 14.7* 
Stroke Volumes        
  TASV (ml) 20.0 ± 4.6 27.2 ± 9.7† 26.3 ± 11.4† 27.8 ± 8.5† 26.6 ± 10.0† 26.3 ± 9.5† 
  PSV (ml) 12.0 ± 4.6 12.8 ± 8.6 11.2 ± 10.8 13.9 ± 6.6 12.1 ± 7.3 14.3 ± 9.1 
  AASV (ml) 8.0 ± 3.2 14.4 ± 8.1† 15. 0± 10.5† 13.9 ± 6.0† 17.4 ± 9.4† 12.6 ± 6.8† 
Emptying fractions        
  TAEF (%) 55.3 ± 9.8 42.8 ± 15.5† 40.8 ± 16.9† 44.3 ± 14.8† 41.1 ± 14.9†‡ 45.6 ± 15.6† 
  PAEF (%) 33.5 ± 11.6 19.9 ± 14.5† 16.8 ± 16.1† 22.2 ± 13.1† 15.7 ± 9.3† 23.6 ± 16.9† 
  AAEF (%) 33.3 ± 9.5 28.6 ± 14.3 27.8 ± 17.6 29.3 ± 11.9 29.4 ± 17.3 29.0 ± 12.5 
 
*p <0.0001 vs. Controls; †p <0.05 vs. Controls; ‡p <0.05 vs. HCM patients with MR <2 
 
Abbreviations: Vmax: maximal left atrial volume, Vmin: minimal left atrial volume, VpreA: volume before atrial contraction, TASV: total 
atrial stroke volume, TAEF: total atrial emptying fraction, AASV: active atrial stroke volume, AAEF: active atrial emptying fraction, PSV: 
passive stroke volume, PAEF: passive atrial emptying fraction, DM: diabetes mellitus, HCM: hypertrophic cardiomyopathy, MR: mitral 
regurgitation 
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Table 8. Comparison of 3DSTE-derived left atrial strain parameters of patients with hypertrophic cardiomyopathy and controls 
 
Controls 
(n=23) 
HCM patients 
(n=23) 
HCM patients 
with 
hypertension 
and/or DM 
(n=10) 
HCM patients 
without 
hypertension 
and/or DM 
(n=13) 
HCM patients 
with MR ≥2 
(n=9) 
HCM 
patients with 
MR <2 
(n=14) 
Global strains       
  Radial strain (%) -19.6 ± 11.7 -12.2 ± 6.7* -14.5 ± 8.5 -10.4 ± 4.4* -12.1 ± 5.8 -12.3 ± 7.4† 
  Circumferential strain (%) 29.8 ± 12.1 26.5 ± 16.5 26.4 ± 19.1 26.6 ± 15.0 25.3 ± 15.9 27.2 ± 17.4 
  Longitudinal strain (%) 23.9 ± 6.3 18.0 ± 7.4* 18.0 ± 6.8† 18.0 ± 8.1† 15.8 ± 6.4* 19.4 ± 7.9 
  3-dimensional strain (%) -12.5 ± 10.2 -6.1 ± 4.4* -7.9 ± 5.1 -4.7 ± 3.3* -6.6 ± 4.8 -5.8 ± 4.2† 
  Area strain (%) 59.0 ± 19.1 49.3 ± 27.8 51.0 ± 31.2 48.0 ± 26.2 44.4 ± 27.3 52.3 ± 28.7 
Mean segmental strains       
  Radial strain (%) -23.7 ± 11.5 -16.3 ± 10.7† -18.6 ± 8.6 -14.6±3.2* -16.2 ± 5.7 -16.4 ± 6.9† 
  Circumferential strain (%) 38.6 ± 23.5 29.9 ± 18.2 31.3 ± 17.9 28.8 ± 15.1 26.8 ± 17.1 31.9 ± 15.6 
  Longitudinal strain (%) 30.6 ± 17.7 20.1 ± 12.4† 20.5 ± 6.1 19.7±7.9† 17.9±5.9† 21.4 ± 7.6 
  3-dimensional strain (%) -17.0 ± 9.5 -10.7 ± 8.3† -12.3 ± 5.8 -9.4 ± 2.5* -11.0 ± 4.3 -10.5 ± 4.6† 
  Area strain (%) 75.9 ± 41.7 54.1 ± 33.2† 56.4 ± 32.2 52.4 ± 26.3 49.4 ± 29.5 57.1 ± 28.3 
 
*p <0.01 vs. Controls; †p <0.05 vs. Controls; ‡p <0.05 vs. HCM patients with MR <2 
 
Abbreviations: DM=diabetes mellitus, HCM=hypertrophic cardiomyopathy, MR=mitral regurgitation 
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4.5. Visualisation of left atrial appendage by three-dimensional speckle-tracking 
echocardiography 
 
Case study. We present a 48-year male patient with hypertrophic cardiomyopathy who was 
examined by 3DSTE. First, LA was looked for in apical 4-chamber and 2-chamber views. 
Later on, longitudinal sectional planes were optimalized to the LA appendage (LAA) in 
perpendicular planes (Figures 12A and 12B). Then cross-sectional views were chosen just 
above the ostium of the LAA (Figure 12C7), at the middle of the LAA (Figure 12C5) and just 
below the apex of the LAA (Figure 12C3). Following manual corrections, a 3D cast of the 
LAA has been created (Figure 12D). Maximum (EDV), minimum (ESV) LAA volumes, 
ejection fraction and mass of the LAA are also presented (Figure 12E). Moreover, rotational 
characteristics of this LAA could also be demonstrated (Figure 12F). 
 
 
Figure 12. Visualisation of the left atrial appendage (LAA) by three-dimensional 
speckle-tracking echocardiography. Following optimalization of longitudinal sectional 
planes to the LAA in perpendicular planes (A and B), cross-sectional views were chosen 
at the ostium of the LAA (C7), at the middle of the LAA (C5) and just before the apex of 
the LAA (C3). Following manual corrections, a 3D cast of the LAA has also been created 
(D). Maximum (EDV), minimum (ESV) LAA volumes, ejection fraction and mass of the 
LAA are also presented (E) together with its rotational characteristics (F). 
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5. Discussion 
 
5.1. Comparison of three-dimensional speckle-tracking echocardiography and two-
dimensional echocardiography for evaluation of left atrial size and function in healthy 
volunteers 
 
Results of the present study could suggest feasibility of 3DSTE in detection of cyclic changes 
in LA volumes and calculation of its functional properties. To the best of authors’ knowledge 
this is the first study to directly compare 3DSTE with 2D echocardiography for the evaluation 
of volumetric and functional LA parameters.  
LA volume has been identified as a potential biomarker for different cardiovascular 
diseases (2). However, during evaluation of volumes phasic function of the LA should be 
respected including: 
1) a reservoir during LV systole („Reservoir function”) 
2) a conduit for blood transiting from the pulmonary veins to the LV during early 
diastole („Conduit function”) 
3) an active contractile chamber that augments LV ventricular filling in late diastole 
(„Active contraction”) 
These phases of the LA function could be characterized by several parameters based on 
accurate measurement of maximum and minimum LA volumes (Vmax and Vmin) and LA 
volume before atrial contraction (VpreA) (6,7). 2D echocardiographic evaluation of LA is 
standardized for a decade and provides reasonable assessment of LA volumes (3), although all 
measurement methods underestimate LA volumes with 14-37% as compared to computed 
tomography (CT) (28) and magnetic resonance imaging (MRI) (29). A minor non-significant 
improvement in the evaluation of LA could be obtained by the early generation multiplane 3D 
echocardiographic method based on 90 images acquired by apical probe rotation (29). Anwar 
et al. demonstrated the feasibility and reproducibility of direct volumetric RT3DE in the 
detection of cyclic changes in LA volumes and calculation of its function as compared to 2D 
echocardiography (6,7).  
Recently, 3DSTE has been introduced, firstly to provide a comprehensive assessment 
of LV function through strain analysis in four dimensions (11,30-32). 3DSTE uses different 
algorithm as compared to RT3DE which is based on block matching of the myocardial 
speckles of the endocardial border during their motion from frame-to-frame (33). This new 
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3DSTE technique for LV volume measurements has been validated and its superior accuracy 
and reproducibility over previously used 2DSTE have even been demonstrated by MRI (30). 
Good intra-observer, inter-observer, and test-retest reliability were found supporting the use 
of 3DSTE for routine evaluation of LV volumes and ejection fraction (32). Kleijn et al. were 
the first to demonstrate that 3D echocardiography with direct volumetric (RT3DE) and 
speckle-tracking methods (3DSTE) give comparable and reproducible quantification of LV 
and LA volumes and function, making interchangable application a viable option in daily 
clinical practice (11). Nagaya et al. aimed to validate the accuracy of 3DSTE and 2DSTE for 
the assessment of LA volume and function by comparison with 3D-CT (34). 3DSTE allowed 
more accurate measurement of LA volume and function than 2DSTE and had high 
reproducibility (34). Results of the present study are in agreement with these findings 
demonstrating feasibility and reproducibility of 3DSTE in the evaluation of LA volumes and 
functional properties. Good correlations were found between measured volumetric and 
calculated functional properties between 2D echocardiography and 3DSTE. Despite image 
quality for 3DSTE is worse due to low temporal and spatial image resolutions than 2D 
echocardiography, but 3D echo visualizes LA as it truly is: 3D organ. This advantage of 
3DSTE (and RT3DE) could highlight our attention on this new technology which probably 
will be a milestone in the echocardiographic evaluation of LA volumes and functional 
properties. 
 
Study limitations. However, some important limitations should be taken into consideration 
analyzing our results: 
(1) LA appendage for calculation of LA volume and function was not included due to its 
variability in shape and lack of standard figures (6).  
(2) The current image quality obtained by 3DSTE is worse than for 2D echocardiography 
due to low temporal and spatial image resolutions.  
(3) This was a single-centre experience and limited by a relatively small number of 
healthy volunteers. The study would have been statistically stronger, if larger number 
of subjects had been evaluated. Caution should be taken when interpreting the results 
observed. 
(4) Although 3DSTE seems to be feasible for the assessment of strain, rotational, 
synchronicity characteristics of LA, the present study did not aimed to evaluate and 
validate these parameters (23). 
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5.2. Relationship between mitral annular and left atrial function as assessed by three-
dimensional speckle-tracking echocardiography in healthy volunteers 
 
To the best of the authors’ knowledge, this is the first study, which examines the relationship 
between 3DSTE-derived LA and MA morphological and functional parameters in healthy 
volunteers. While (systolic) maximal LA volume (Vmax) correlated with both the systolic and 
diastolic MA parameters, (diastolic) minimal LA volume (Vmin) and LA volume before atrial 
contraction (VpreA) correlated only with systolic MA parameters. Systolic TASV showed 
correlated with both systolic and diastolic MA characteristics, diastolic PASV correlated only 
with diastolic MA parameters. Nor the AASV neither any of emptying fractions showed 
correlations with MA morphological and functional parameters. LA volumes did not show 
correlations with MA functional characteristics, while the (systolic) TASV and (diastolic) 
PASV correlated with MA fractional shortening.  
The saddle–shaped two-leaflet (bicuspid) mitral valve situates between the LA and LV, 
regulating the blood flow between these chambers by the help of papillary muscles and 
tendon-chords (35). During diastole the normal mitral valve opens by the effect of the 
elevated LA pressure and the blood flows into the LV. In the initial phase of diastole LA 
works like a “conduit” (channel), i.e. it provides the bloodstream from the pulmonary veins 
into the LV. Diastole ends with LA contraction, which is responsible for the 20% of the total 
streaming blood (36,37). Normally in systole with the closure of the mitral valve the blood 
does not flow back from the LV to the LA, but it flows via the aortic valve to the aorta. 
Simultaneously the LA is filled back from the pulmonary veins and reaches the maximal 
capacity volume (reservoir function). The above-mentioned mechanism opens the door to 
maintain the normal cardiac pump function, in which the mitral valve and its annulus (MA) 
have an important role. The change of the function and size of the MA can be associated with 
several diseases (cardiomyopathies, myocardial infarction, etc.), which can affect the LA and 
LV functions with feedback mechanism (e.g. effects of consequential mitral regurgitation, 
etc.) (35). In the present study we have found the above-mentioned relationships between the 
morphological and functional MA and LA parameters even in healthy volunteers by 3DSTE.  
As mentioned previously, both early 3D echocardiographic methods (38), and RT3DE 
are proved to be suitable for the measurement of LA volumes (4,6,7). 3DSTE is a new clinical 
method, which is a suitable procedure for describing the volumes and functions of the 
chambers with the help of 3D strain analysis (5,30). 3DSTE was found to be an accurate and 
reproducible method for assessment of LA volumes and volume-based functional and strain 
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functional properties when it was compared to 2D echocardiography, 2DSTE, RT3DE and CT 
(5,11,23,34). 3DSTE-derived LA strain values showed alterations in atrial fibrillation (21,22) 
and in HCM (39). 
During 3D echocardiography not only LA volumes and functional properties, but the 
mitral valve and its annulus (MA) could be described simultaneously, as well (4). Its reason 
could be found in the method giving opportunity to the “en-face”, i.e. front-wise examination 
of the valves (4). RT3DE was found to be a suitable method for the measurement of MA 
diameter (MAD) and area (MAA), and it was confirmed that 2D echocardiography 
underestimates these morphological parameters (8). RT3DE-derived MAD and MAA proved 
to be larger in case of cardiomyopathy, while it was associated with more significant MA 
function in HCM, MA function proved to be reduced in dilated and noncompaction 
cardiomyopathy (9,10 ). Up to the present the available literature dealing with 3DSTE is 
limited, but it seems to be a suitable procedure for calculation of MA morphological and 
functional parameters (40). 
 
Study limitations. During the analysis of our data, the following important limiting factors 
occurred over that ones previously mentioned: 
(1) The aim of our present study was the evaluate LA and MA by 3DSTE. The 
assessment of LV and other heart chambers by 3DSTE was not the subject of this 
study. 
(2) Further studies are warranted in connection with validity of 3DSTE-derived MA or 
other valvular data. 
 
 
5.3. Alternative ways to assess left atrial function in noncompaction cardiomyopathy by 
three-dimensional speckle-tracking echocardiography 
 
To the best of authors’ knowledge this is the first report to demonstrate the clinical usefulness 
of 3DSTE in the evaluation LA function in NCCM. Recently, direct volumetric RT3DE was 
found to be useful to assess isolated LV-NCCM alone (41–48), or in combination with 
Ebstein’s anomaly (49) or double-orifice mitral valve (50). Moreover, isolated right 
ventricular (51) and biventricular forms were also evaluated by RT3DE (52). In a larger series 
of NCCM patients, noncompacted and compacted LV segments had comparable increased 3D 
regional volumes and reduced systolic function suggesting that systolic LV dysfunction is not 
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confined to noncompacted LV segments (53). In a RT3DE study, both LV trabecular mass as 
well as the total number of trabeculations in NCCM patients were significantly 
underestimated by 2D echocardiography as compared to RT3DE (54). MA could be also 
assessed ’en-face’ by RT3DE and was found to be enlarged and functionally impaired in 
NCCM patients, with a higher incidence and severity of MR (10). LA-EFO was increased in 
NCCM patients compared to normal individuals suggesting compensating LA work against 
the dysfunctional LV in NCCM patients (26). 3D-STE-derived LA-EFO of the present 
NCCM case was in the range previously given by RT3DE (26). 
STE is a promising new echocardiographic method, with which LV strain, rotational 
and twist parameters can be non-invasively assessed. Van Dalen et al. were the first to 
demonstrate that 2DSTE-derived 'LV solid/rigid body rotation', with near absent LV twist, 
may be a new sensitive and specific, objective and quantitative, functional diagnostic criterion 
and have good predictive value for the diagnosis of NCCM (55,56). LV myocardial 
deformation was also found to be reduced in the longitudinal and circumferential dimensions 
and manifested tight systolic-diastolic coupling in children with NCCM (57).  
As demonstrated in this report, 3DSTE could help in the evaluation of LA function in 
3D space. However, due to limited number of NCCM reports, further clinical studies with 
3DSTE in series of NCCM patients are warranted, especially focusing on assessment of 
regional LA and LV strain, rotational and twist parameters. 
 
 
5.4. Three-dimensional speckle-tracking echocardiography allows detailed evaluation of 
left atrial function in hypertrophic cardiomyopathy 
 
To the best of authors’ knowledge this is the first study in which increased LA volumes and 
TASV and AASV could be demonstrated in patients with HCM by 3DSTE. Moreover, TAEF 
and PAEF proved to be significantly decreased. 3DSTE-derived strain parameters were also 
reduced in HCM patients as compared to matched controls. These data could draw our 
attention to the fact that 3DSTE enables more detailed evaluation of LA dysfunction including 
detection of volumetric changes respecting its motion during heart cycle, even in HCM. 
Moreover, evaluation of different strains at the same time seems to be a quantitative way to 
demonstrate LA functional abnormalities.  
As already mentioned, several non-invasive imaging methods including M-mode and 
2D Doppler echocardiography (3,58), 2DSTE (59), tissue-Doppler imaging (TDI) (59), 
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RT3DE (11, 60), cine CT (61), cardiac MRI (62) etc. have been used for evaluation of LA 
dimensions, volumes and function. As mentioned in the previous chapters, 3DSTE has just 
been introduced, which encompasses benefits of STE and 3D echocardiography. Over 
assessment of LA volumetric and functional properties, 3DSTE seems to be reliable method 
for the accurate measurement of LV volumes respecting cardiac cycle (30,63,64). 3DSTE is 
also able to quantify regional and global LV myocardial deformation by strain analysis from a 
single data aquisition (31,65,66). 3DSTE is a non-invasive tool for quantification of rotational 
and twist LV mechanics, as well (67-69). Several calculated dyssynchrony parameters of the 
LV have been demonstrated by different authors (70-72). Some specific case report suggested 
its role in the evaluation of LA appendage (73) and quantification of right ventricular volumes 
(74) and aortic root rotation (75), etc. However, its clinical utility in the evaluation of the 
heart and large vessels is not fully described in the literature. 
 Increased volumes and impaired LA myocardial deformation are known features in 
HCM (76). Moreover, occurrence of myocardial fibrosis in HCM was found to be associated 
with LA dysfunction (77). Abnormalities in strain theoretically could be due to chronically 
high LA pressures from diastolic dysfunction, LV outflow tract obstruction or higher grade 
MR, but intrinsic abnormalities including fibrosis of the LA wall should also be considered. 
However, further studies are warranted to examine whether relationship exists between 
dynamic obstruction and LA functional parameters detailed above. Moreover, the effect of 
alcohol septal ablation on these parameters could be also a subject of research.  
 
Limitation section. Over the previously mentioned limitations the following important ones 
should be taken into consideration: 
(1) 3DSTE seems to be a feasible method for volumetric (11,23) and strain (21,22) 
assessment of the LA. Despite several non-invasive tools (TDI, RT3DE, 2DSTE, 
CMR, CT, etc.) could be used to quantify LA volumes and function (6,7,11,58-62), 
only limited number of studies are available, in which 3DSTE was compared to these 
widely used and accepted methodologies (11,23). Therefore, more comparative studies 
with other methods are warranted especially focusing on the limitations of 3DSTE. 
(2) 3DSTE-derived strain parameters of healthy subjects were somewhat different from 
the results of previous studies (21,22). It could be explained by the fact, that these 
parameters depend on the place of measurement (basal-mid-superior regions etc.), 
even in healthy subjects. Moreover, the values are affected by the age, and other 
factors, as well (78).  
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(3) Despite the fact that LA appendage could be analysed by modern transthoracic 
echocardiographic methodologies including TDI (79,80), 3DSTE (73) etc, LA 
appendage and pulmonary veins were excluded from evaluations.  
(4) There are several aspects of HCM including genetic background, history of embolism, 
development of arrhythmias, etc., their relationship to the LA dysfunction was not 
examined in the present study. 
(5) The effects of dynamic obstructions on LA functional parameters were not examined 
in this study.   
(6) LA function deteriorated in patients with sick sinus syndrome and in those with 
paroxysmal atrial fibrillation (22). However, all of our patients and controls were in 
sinus rhythm. 
 
 
5.5. Visualisation of left atrial appendage by three-dimensional speckle-tracking 
echocardiography 
 
To the best of authors’ knowledge this is the first case, in which usefulness of 3DSTE is 
presented for the volumetric and functional evaluation of LAA. The presented method seems 
to be easy to perform, but highly depends on the image quality (worse than 2D 
echocardiography), extent and complexity of LAA (large one-lobe LAA could be assessed as 
the presented case), etc. Therefore, further comparative studies with larger number of healthy 
subjects and pathological cases are warranted to demonstrate feasibility of 3DSTE in the 
assessment of LAA. 
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6. Conclusions (new observations) 
 
Three-dimensional speckle-tracking echocardiography is feasible in the detection of cyclic 
changes in left atrial volumes and calculation of its functional properties is comparable to 
two-dimensional echocardiography. 
 
Three-dimensional speckle-tracking echocardiography is a proper method for the 
simultaneous evaluation of left atrial and mitral annular morphological and functional 
characteristics. Correlations exist between left atrial and mitral annular morphological and 
functional parameters in healthy subjects. 
 
Three-dimensional speckle-tracking echocardiography could help in the detailed evaluation of 
left atrial dysunction in noncompaction cardiomyopathy by several ways. 
 
Three-dimensional speckle-tracking echocardiography allows evaluation of LA dysfunction 
by volumetric and strain analysis in hypertrophic cardiomyopathy.  
 
In special cases three-dimensional speckle-tracking echocardiography allows volumetric and 
functional assessment of a left atrial appendage by a simple non-invasive way. 
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